Synthesis of α-aminoacyl derivatives of melphalan for use in antibody directed enzyme pro-drug therapy
- 12 March 1999
- journal article
- Published by Elsevier in Tetrahedron
- Vol. 55 (11), 3265-3276
- https://doi.org/10.1016/s0040-4020(98)01139-9
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Activation and cytotoxicity of 2-α-aminoacyl prodrugs of methotrexateBiochemical Pharmacology, 1995
- Prodrugs of doxorubicin and melphalan and their activation by a monoclonal antibody-penicillin-G amidase conjugateJournal of Medicinal Chemistry, 1993
- Tumour markers in oncology: past, present and futureJournal of Immunological Methods, 1992
- Antibody-penicillin-V-amidase conjugates kill antigen-positive tumor cells when combined with doxorubicin phenoxyacetamideCancer Immunology, Immunotherapy, 1990
- Activation of prodrugs by antibody‐enzyme conjugates: a new approach to cancer therapyThe FASEB Journal, 1990
- Melphalan transport into human malignant lymphoid cells differs from the murine equivalent in vitroBritish Journal of Cancer, 1989
- Antibody directed enzymes revive anti-cancer prodrugs conceptBritish Journal of Cancer, 1987
- Human Tumor AntigensAdvances in Immunology, 1987
- Cytotoxicity as an indicator for transport mechanism. Evidence that melphalan is transported by two leucine-preferring carrier systems in the L1210 murine leukemia cellBiochimica et Biophysica Acta (BBA) - Biomembranes, 1979
- Cyto-active amino-acid and peptide derivatives. Part I. Substituted phenylalaninesJournal of the Chemical Society, 1954